IP Library Granted Patent US 7,678,919
Granted Patent B2
US 7,678,919 · App. 12/238,070 · Granted Mar 16, 2010

Method for producing pentacyclic taxans

Assignee: Daiichi Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,678,919
App. No.
12/238,070
Granted
Mar 16, 2010
Kind
B2
Abstract

Taxan derivatives are produced efficiently and inexpensively, which are useful as oral-administrable antitumor compounds. A compound of formula (1) (wherein R 1 is an alkyl group, an alkenyl group, an alkynyl group, a cycloalkyl group, an aryl group or a heterocyclic group; R 2 is a hydroxyl group optionally having a protective group) is processed with an alkali metal permanganate to produce a compound of formula (2), which may be a starting material for oral-administrable antitumor compounds.

Claims (9)

1. A method for producing a compound of the following general formula (11) or its salt, which comprises reacting a compound of the following general formula (14):

(in formula (14), boc means a tert-butoxycarbonyl group; TIPS means a triisopropylsilyl group), with a compound of the following general formula (19):

(in formula (19), Ac means an acetyl group; and Bz means a benzoyl group)

to produce a compound of the following general formula (7):

(in formula (7), boc, Ac, Bz and TIPS have the same meanings as above), then reacting the compound of formula (7) with potassium permanganate in aqueous pyridine to obtain a compound of the following general formula (8):

(in formula (8), boc, Ac, Bz and TIPS have the same meanings as above), reacting the compound of formula (8) with an alkali metal periodate, and then with sodium acetoxyborohydride in the presence of acetic acid and dimethylamine to obtain a compound of the following general formula (9):

(in formula (9), boc, Ac, Bz and TIPS have the same meanings as above), and then reacting the compound of formula (9) with a palladium-carbon catalyst in the presence of hydrogen gas to thereby reduce the compound of formula (9) into a compound of the following general formula (10):

(in formula (10), boc, Ac, Bz and TIPS have the same meanings as above), and thereafter reacting the compound of formula (10) with a fluoroammonium salt to produce a compound of the following general formula (11) or its salt:

(in formula (11), boc, Ac and Bz have the same meanings as above).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 2, 2017
From: IMURA, AKIHIRO; YAMAGUCHI, TATSUYA; TAKAYANAGI, YOSHIHIRO; UCHIDA, SEISHIRO
To: DAIICHI PHARMACEUTICAL CO., LTD.
Reel/Frame 043175/0321 →
MERGER Recorded Aug 2, 2017
From: DAIICHI PHARMACEUTICAL CO., LTD.
To: DAIICHI SANKYO COMPANY, LIMITED
Reel/Frame 043760/0556 →
Priority Claims (1)
JP 2004-136359 · Apr 30, 2004 · national
Continuity (2)
Division 1157914000
Related Publication 20090030209A1 · Jan 29, 2009